跳至主要内容
临床试验/CTRI/2023/08/056849
CTRI/2023/08/056849招募中3 期

Posterior cervical fixation versus long-term cervical collar for management of Hirayama Disease: Prospective randomized open blinded endpoint (PROBE), phase III study

All India Institute of Medical Sciences1 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2023年10月31日最近更新:

试验速览

阶段
3 期
状态
招募中
入组人数
80
试验地点
1
主要终点
1)To determine & compare the efficacy of posterior cervical fixation versus cervical collar in patients with Hirayama disease in terms of Odom’s criteria at six months after randomization.

研究概览

简要总结

1.      Research Hypothesis:The surgical intervention is superior to neck immobilization using a cervical collar in Hirayama disease in terms of clinical and radiological improvement at six months after surgery.

2.      Background and Rationale of the StudyHirayama disease (HD), also known as juvenile muscular atrophy, or monomelic amyotrophy (MMA) affecting the upper extremity, is a special neurological disorder first brought to attention by a Japanese neurologist, Keizo Hirayama in 1959.(5) In India, similar cases, as well as variants, have been published (6). The disease predominantly affects males in their second decade (3) and leads to considerable morbidity in their economically productive stage of life. The long-term follow-up studies of HD have shown that the patients progressed for 4-5 years before stabilization of the disease but with significant residual neurological deficits.(7) The putative etiology described is dynamic compression of the cervical dural canal in flexed neck posture causing dynamic compression and ischemia of lower cervical cord (5), while post-infectious (3) and genetic (8,9) etiologies have also been postulated.

Although several surgical interventions are described (4), there is a glaring evidence-practice gap in management. The evidence of surgical benefit is limited to case series(10–12), or case-control studies. (2) In the modified Delphi technique to understand the diagnosis and treatment of HD, 40.5% of experts opted for surgical treatment when the disease duration is less than 4 years and there has been disease progression in the past 6 months, while 38.1% opted for conservative treatment and 21.4% were neutral.(13) A recent case-control study (2) found 76% in the surgical group had clinical improvement while none in the conservative group. This huge effect size should be exploited to benefit young patients, by generating a level I evidence.

The rationale of surgical intervention in patients with HD is to immobilize the spine in extension to prevent compression over the cervical spinal cord, which occurs in flexion. The use of several surgical approaches in patients with HD have been described in the literature. The rate of neurological improvement has been found to be similar between anterior and posterior surgical approaches in a recent meta-analysis.(4) It has shown that posterior cervical fixation carries the least risk of blood loss. Hence, we have chosen this surgical approach.

References:

1.         Wang H, Tian Y, Wu J, Luo S, Zheng C, Sun C, et al. Update on the Pathogenesis, Clinical Diagnosis, and Treatment of Hirayama Disease. Front Neurol [Internet]. 2022 [cited 2022 Mar 9];12. Available from: https://www.frontiersin.org/article/10.3389/fneur.2021.811943

2.         Thakar S, Arun AA, Rajagopal N, Aryan S, Mohan D, Vijayan JE, et al. Outcomes after Cervical Duraplasty for Monomelic Amyotrophy (Hirayama Disease): Results of a Case–Control Study of 60 Patients. J Neurosci Rural Pract. 2021 Sep 22;12(4):642–51.

3.         Vibha D, Behari M, Goyal V, Shukla G, Bhatia R, Srivastava AK, et al. Clinical profile of Monomelic Amyotrophy (MMA) and role of persistent viral infection. J Neurol Sci. 2015 Dec 15;359(1–2):4–7.

4.         Bohara S, Garg K, Mishra S, Tandon V, Chandra PS, Kale SS. Impact of various cervical surgical interventions in patients with Hirayama’s disease—a narrative review and meta-analysis. Neurosurg Rev. 2021 Dec;44(6):3229–47.

5.         Hirayama K, Tomonaga M, Kitano K, Yamada T, Kojima S, Arai K. Focal cervical poliopathy causing juvenile muscular atrophy of distal upper extremity: a pathological study. J Neurol Neurosurg Psychiatry. 1987 Mar 1;50(3):285–90.

6.         Gourie-Devi M, Suresh TG. Madras pattern of motor neuron disease in South India. J Neurol Neurosurg Psychiatry. 1988 Jun;51(6):773–7.

7.         A N, M GD, K T, Ah R. Monomelic amyotrophy: clinical profile and natural history of 279 cases seen over 35 years (1976-2010). Amyotroph Lateral Scler Front Degener [Internet]. 2014 Sep [cited 2022 Mar 14];15(5–6). Available from: https://pubmed.ncbi.nlm.nih.gov/24853410/

8.         Atchayaram N, Vasudev MK, Goel G. Familial monomelic amyotrophy (Hirayama disease): two brothers with classical flexion induced dynamic changes of the cervical dural sac. Neurol India. 2009 Dec;57(6):810–2.

9.         Lim YM, Koh I, Park YM, Kim JJ, Kim DS, Kim HJ, et al. Exome sequencing identifies KIAA1377 and C5orf42 as susceptibility genes for monomelic amyotrophy. Neuromuscul Disord NMD. 2012 May;22(5):394–400.

10.       Lu F, Wang H, Jiang J, Chen W, Ma X, Ma X, et al. Efficacy of anterior cervical decompression and fusion procedures for monomelic amyotrophy treatment: a prospective randomized controlled trial: Clinical article. J Neurosurg Spine. 2013 Oct 1;19(4):412–9.

11.       Song J, Cui ZY, Chen ZH, Jiang JY. Analysis of the Effect of Surgical Treatment for the Patients with Hirayama Disease from the Perspective of Cervical Spine Sagittal Alignment. World Neurosurg. 2020 Jan 1;133:e342–7.

12.       Zhang H, Wang S, Li Z, Shen R, Lin R, Wu W, et al. Anterior Cervical Surgery for the Treatment of Hirayama Disease. World Neurosurg. 2019 Jul 1;127:e910–8.

13.       Lyu F, Zheng C, Wang H, Nie C, Ma X, Xia X, et al. Establishment of a clinician-led guideline on the diagnosis and treatment of Hirayama disease using a modified Delphi technique. Clin Neurophysiol Off J Int Fed Clin Neurophysiol. 2020 Jun;131(6):1311–9.

14.       Broekema AEH, Molenberg R, Kuijlen JMA, Groen RJM, Reneman MF, Soer R. The Odom Criteria: Validated at Last: A Clinimetric Evaluation in Cervical Spine Surgery. J Bone Joint Surg Am. 2019 Jul 17;101(14):1301–8.

15.       Sletten DM, Suarez GA, Low PA, Mandrekar J, Singer W. COMPASS 31: A Refined and Abbreviated Composite Autonomic Symptom Score. Mayo Clin Proc. 2012 Dec 1;87(12):1196–201.

16.       Gourie-Devi M, Suresh TG, Shankar SK. Monomelic Amyotrophy. Arch Neurol. 1984 Apr 1;41(4):388–94.

研究设计

研究类型
Interventional
分配方式
Permuted block randomization, variable
盲法
Open Label

入排标准

年龄范围
18.00 Year(s) 至 50.00 Year(s)(—)
性别
All

入选标准

  • (1)Age ≥ 18 years (2)Patients with Hirayama disease as per the following criteria (All of the following): a.Clinical evidence of wasting and weakness confined to one limb (EMG evidence of denervation in the opposite limb will not be a reason for exclusion) b.Progressive course, or initial progression followed by stationary course; and c.No evidence of a compressive lesion of the spinal cord.
  • (3)Disease duration of ≤4 years (4)Progression of clinical symptoms in the past six-months.

排除标准

  • Any of the following: (1)Refusal to consent for randomization.
  • (2)Not willing to come for three- and six-months follow-up.

结局指标

主要结局

1)To determine & compare the efficacy of posterior cervical fixation versus cervical collar in patients with Hirayama disease in terms of Odom’s criteria at six months after randomization.

时间窗: Six months

次要结局

  • 1)To determine & compare the efficacy of posterior cervical fixation versus cervical collar in patients with Hirayama disease in terms of Odom’s criteria at three months after randomization.(Three months)
  • 2) To compare MRI DTI parameter in two groups(Six months)
  • 3) Compare clinical & electrophysiological features in two groups(Six months)

研究者

申办方类型
Government medical college

研究点 (1)

Loading locations...

相似试验

Comparison of Surgery versus cervical collar... | 临床试验